124 related articles for article (PubMed ID: 14759717)
1. Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy.
Myles JP; Salmininen T; Duffy SW; Prevost TC; Day NE; Hakama M
Breast; 2004 Feb; 13(1):56-60. PubMed ID: 14759717
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hormone replacement therapy on the mammographic density of the female breast].
Egyed Z; Péntek Z; Magyar Z
Magy Onkol; 2005; 49(4):319-21, 323-5. PubMed ID: 16518476
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
4. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern.
Laya MB; Gallagher JC; Schreiman JS; Larson EB; Watson P; Weinstein L
Radiology; 1995 Aug; 196(2):433-7. PubMed ID: 7617857
[TBL] [Abstract][Full Text] [Related]
5. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
6. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
7. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
[TBL] [Abstract][Full Text] [Related]
8. Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy?
Salminen TM; Saarenmaa IE; Heikkilä MM; Hakama M
Acta Oncol; 2000; 39(8):969-72. PubMed ID: 11207004
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
10. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
[TBL] [Abstract][Full Text] [Related]
11. Association between mammographic parenchymal pattern classification and incidence of breast cancer.
Threatt B; Norbeck JM; Ullman NS; Kummer R; Roselle P
Cancer; 1980 May; 45(10):2550-6. PubMed ID: 7378990
[TBL] [Abstract][Full Text] [Related]
12. Mammographic breast density changes after 1 year of tibolone use.
Kutlu T; Fiçicioğlu C; Başaran T; Başaran E; Topaloğlu T
Maturitas; 2004 Jun; 48(2):133-6. PubMed ID: 15172087
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and mammographic screening.
Evans A
Clin Radiol; 2002 Jul; 57(7):563-4. PubMed ID: 12096852
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
15. The effect of hormone replacement therapy on the sensitivity of screening mammograms.
Litherland JC; Stallard S; Hole D; Cordiner C
Clin Radiol; 1999 May; 54(5):285-8. PubMed ID: 10362232
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
17. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography.
Carney PA; Miglioretti DL; Yankaskas BC; Kerlikowske K; Rosenberg R; Rutter CM; Geller BM; Abraham LA; Taplin SH; Dignan M; Cutter G; Ballard-Barbash R
Ann Intern Med; 2003 Feb; 138(3):168-75. PubMed ID: 12558355
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone therapy and mammographic breast density.
Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
[TBL] [Abstract][Full Text] [Related]
20. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
